Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 1
1(20.0%)
5Total
N/A(4)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03529734Not ApplicableUnknown

Changes in Trunk Stability Indicators Following Two Types of Exhausting Physical Activities

Role: collaborator

NCT03440125Phase 1Completed

Cayenne Pepper Cataplasm - Safety Study

Role: collaborator

NCT01985776Not ApplicableCompleted

Effects of Exercise Intervention in Patients With Spondylolisthesis Related LBP

Role: collaborator

NCT03298789Not ApplicableCompleted

Acute Effects of Static Stretching in Warm-up

Role: collaborator

NCT03279380Not ApplicableUnknown

Gene-Exercise Interactions in Athletes

Role: collaborator

All 5 trials loaded